User profiles for Vikram R. Bollineni
 | Vikram rao BollineniNuclear Medicine Imaging Fellow Verified email at umcg.nl Cited by 758 |
PET imaging of tumor hypoxia using 18F-fluoroazomycin arabinoside in stage III–IV non–small cell lung cancer patients
VR Bollineni, GSMA Kerner, J Pruim… - Journal of Nuclear …, 2013 - Soc Nuclear Med
Tumor hypoxia hampers the efficacy of radiotherapy because of its increased resistance to
ionizing radiation. The aim of the present study was to estimate the potential added clinical …
ionizing radiation. The aim of the present study was to estimate the potential added clinical …
Dynamics of tumor hypoxia assessed by 18F-FAZA PET/CT in head and neck and lung cancer patients during chemoradiation: possible implications for radiotherapy …
… Author links open overlay panel Vikram R. Bollineni a , Michel JB Koole b , Jan Pruim b ,
Charlotte L. Brouwer a , Erwin M. Wiegman a , Harry JM Groen c , Renske Vlasman a , Gyorgy B…
Charlotte L. Brouwer a , Erwin M. Wiegman a , Harry JM Groen c , Renske Vlasman a , Gyorgy B…
[HTML][HTML] Preclinical applications of 3'-deoxy-3'-[18F] Fluorothymidine in oncology-a systematic review
S Schelhaas, K Heinzmann, VR Bollineni… - Theranostics, 2017 - ncbi.nlm.nih.gov
The positron emission tomography (PET) tracer 3'-deoxy-3'-[18 F] fluorothymidine ([18 F] FLT)
has been proposed to measure cell proliferation non-invasively in vivo. Hence, it should …
has been proposed to measure cell proliferation non-invasively in vivo. Hence, it should …
High diagnostic value of 18F-FDG PET/CT in endometrial cancer: systematic review and meta-analysis of the literature
VR Bollineni, S Ytre-Hauge… - Journal of Nuclear …, 2016 - Soc Nuclear Med
The aim of this study was to evaluate the diagnostic performance of 18 F-FDG PET/CT for the
preoperative assessment of lymph node metastases (LNM) in endometrial cancer patients …
preoperative assessment of lymph node metastases (LNM) in endometrial cancer patients …
[HTML][HTML] An exploratory study of volumetric analysis for assessing tumor response with 18F-FAZA PET/CT in patients with advanced non-small-cell lung cancer …
GSMA Kerner, VR Bollineni, TJN Hiltermann… - EJNMMI research, 2016 - Springer
Background Hypoxia is associated with resistance to chemotherapy and radiotherapy and
is randomly distributed within malignancies. Characterization of changes in intratumoral …
is randomly distributed within malignancies. Characterization of changes in intratumoral …
Assessment of hypoxic subvolumes in laryngeal cancer with 18F-fluoroazomycinarabinoside (18F-FAZA)-PET/CT scanning and immunohistochemistry
LB de Bruin, VR Bollineni, JE Wachters… - Radiotherapy and …, 2015 - Elsevier
Background and purpose 18 F-fluoroazomycinarabinoside ( 18 F-FAZA) is a promising
hypoxia radiopharmaceutical agent with outstanding biokinetic parameters. We aimed to …
hypoxia radiopharmaceutical agent with outstanding biokinetic parameters. We aimed to …
Residual 18F-FDG-PET uptake 12 weeks after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer predicts local control
VR Bollineni, J Widder, J Pruim, JA Langendijk… - International Journal of …, 2012 - Elsevier
PURPOSE: To investigate the prognostic value of [ 18 F]fluorodeoxyglucose positron emission
tomography (FDG-PET) uptake at 12 weeks after stereotactic ablative radiotherapy (SABR…
tomography (FDG-PET) uptake at 12 weeks after stereotactic ablative radiotherapy (SABR…
Hypoxia imaging using positron emission tomography in non-small cell lung cancer: implications for radiotherapy
VR Bollineni, EM Wiegman, J Pruim, HJM Groen… - Cancer treatment …, 2012 - Elsevier
Tumour hypoxia is an important contributor to radioresistance. Thus, increasing the radiation
dose to hypoxic areas may result in improved locoregional tumour control. However, this …
dose to hypoxic areas may result in improved locoregional tumour control. However, this …
[HTML][HTML] Functional and molecular imaging in cancer drug development
VR Bollineni, S Collette, Y Liu - Chinese Clinical Oncology, 2014 - cco.amegroups.org
Functional and molecular imaging in cancer drug development - Bollineni - Chinese … the
FMISO-PET defined hypoxic volume in an experimental rat tumor model (r=0.9066; P<0.0001). …
FMISO-PET defined hypoxic volume in an experimental rat tumor model (r=0.9066; P<0.0001). …
[HTML][HTML] The prognostic value of preoperative FDG-PET/CT metabolic parameters in cervical cancer patients
VR Bollineni, S Ytre-Hauge, A Gulati, MK Halle… - European Journal of …, 2018 - Springer
Background To explore quantitative metabolic and microstructural primary tumour parameters
at pretreatment FDG-PET/CT and diffusion-weighted-magnetic resonance imaging (DW-…
at pretreatment FDG-PET/CT and diffusion-weighted-magnetic resonance imaging (DW-…